APYX is Apyx Medical Corporation Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $3.05. Market cap: $128M. Capital Quality Rank: 49/100 — Stagnant mediocrity.
Stock snapshot
| Price | $3.05 |
| Market cap | $128M |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 49 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -28.4% |
| Revenue CAGR (3y) | 5.9% |
| Shareholder buyback yield | -13.51% |
| Altman Z-score zone | Distress |
About APYX
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
Related non-dividend companies
Other non-dividend stocks investors research alongside APYX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is APYX's current stock price?
APYX (Apyx Medical Corporation Common Stock) is currently trading at $3.05.
Does APYX pay a dividend?
APYX (Apyx Medical Corporation Common Stock) does not currently pay a regular dividend.
What is APYX's Capital Quality Rank?
APYX has a Capital Quality Rank of 49/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track APYX in DiviDrip
Add APYX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search APYX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.